髓源性抑制细胞在脓毒症中的作用:病理生理、双重性与治疗前沿
本综述概述髓源性抑制细胞(MDSC)生物学,描述其起源于病理性应急髓系生成并分为多形核与单核亚群。MDSC在脓毒症中呈双重角色:早期保护性调节细胞因子风暴,后期演变为与继发感染和死亡相关的有害免疫抑制。机制涉及L-精氨酸耗竭(经精氨酸酶1/诱导型一氧化氮合酶)、氧化应激(活性氧)及诱导调节性T细胞。治疗策略包括靶向MDSC分化(如全反式维甲酸)、代谢(如脂肪酸氧化抑制剂)、精准清除(如抗LOX-1)及微生物组调节,临床转化面临表型异质性、代谢模糊性和MDSC靶向「双刃剑」等挑战。
要点
- 脓毒症诱导的免疫抑制是死亡因素之一,由MDSC密切介导。
- MDSC起源于病理性应急髓系生成,分为多形核与单核亚群。
- MDSC早期保护性调节细胞因子风暴,后期转为有害免疫抑制,与继发感染和死亡相关。
- 机制包括L-精氨酸耗竭(精氨酸酶1/诱导型一氧化氮合酶)、活性氧氧化应激及诱导调节性T细胞。
- 治疗策略涉及全反式维甲酸(分化)、脂肪酸氧化抑制剂(代谢)、抗LOX-1(精准清除)及微生物组调节,但临床转化面临表型异质性、代谢模糊性和靶向双刃剑挑战。
证据类型、等级与局限
- 证据类型:综述。
- 局限:原文未报告局限性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「研究设计与关键结果」「对床旁实践的改变」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Sepsis-induced immunosuppression, one of the factors contributing to mortality, is closely mediated by myeloid-derived suppressor cells (MDSCs). This review first outlines MDSC biology, describing their origin from pathological emergency myelopoiesis and classification into polymorphonuclear and monocytic subsets. We then discuss their dual role: an early, protective modulation of cytokine storm that later evolves into harmful immunosuppression associated with secondary infections and death. The underlying mechanisms involve L-arginine depletion ( via arginase 1/inducible nitric oxide synthase), oxidative stress (reactive oxygen species), and induction of regulatory T cells. Therapeutic strategies are summarized, including interventions targeting MDSC differentiation (e.g., all-trans retinoic acid), metabolism (e.g., fatty acid oxidation inhibitors), precision depletion (e.g., anti-LOX-1), and microbiome modulation. Finally, we address challenges to clinical translation-phenotypic heterogeneity, metabolic ambiguity, and the "double-edged sword" of MDSC targeting. Deeper insights into MDSC biology may help develop strategies to improve outcomes in this severe syndrome.
参考来源
- Qin S, Kang Z, Wu Q, et al. Myeloid-Derived Suppressor Cells in Sepsis: Pathophysiology, Duality, and Therapeutic Frontiers. Shock. 2026. PMID: 41823710. doi:10.1097/SHK.0000000000002817
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。